Boosting betaine may be a treatment for schizophrenia
Supplementing model mice with glycine betaine (trimethylglycine), a compound originally derived from beets, can alleviate symptoms of schizophrenia.
Jun 27
Supplementing model mice with glycine betaine (trimethylglycine), a compound originally derived from beets, can alleviate symptoms of schizophrenia.
Jun 19
Gray matter volume links symptoms in autism
Low gray matter volume in the posterior superior parietal lobule (pSPL) was found to correlate with specific cognitive and perceptual symptoms of autism.
Jun 6
CAPON links Alzheimer’s plaques to neurodegeneration
CAPON was found to link Aβ plaques and hippocampal neurodegeneration in mice, explaining how these two hallmarks of Alzheimer’s disease are related.
May 20
AdR blockers protect the brain from stroke damage
Treatment with adrenergic receptor antagonists (AdR blockers) was able to reduce stroke-related brain damage in mice and improve motor recovery.
Apr 25
Trigger region found for epileptic absence seizures
A mouse model shows that absence seizures are triggered by faulty connections between the cortex and fast-spiking neurons in the striatum.
Apr 23
Opto-OISI: imaging connections in the living brain
A new imaging technique called opto-OISI allows scientists to non-invasively visualize where specific neurons project in the living brain.
RIKEN at a Glance
30-day trend
- November 26, 2020
Bacterial drug resistance studied by robotic E. coli evolution - December 27, 2015
Black smokers and electroecosystems - February 15, 2022
Green hydrogen production for fuel cells and fertilizers - October 16, 2024
Protein antigens in meat, milk, and other foods suppress gut tumors - August 7, 2024
Dopamine reduces beta-amyloid plaques in Alzheimer’s disease
Topics
